Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaquesThomas A. Waldmann, Stephen P. Creekmore, Carolyn K. Goldman et al.|Blood|2011Cited by 194
Reduced Inflammation and Lymphoid Tissue Immunopathology in Rhesus Macaques Receiving Anti–Tumor Necrosis Factor Treatment During Primary Simian Immunodeficiency Virus InfectionBrian Tabb, Jacob D. Estes, David R. Morcock et al.|The Journal of Infectious Diseases|2012Cited by 61
Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaquesRachele M. Bochart, Jeremy Smedley, Kathleen Busman‐Sahay et al.|PLoS Pathogens|2021Cited by 15